Oridonin supplementation in rabbits may help to improve the outcome of induced atherosclerosis via autophagy induction Effects of oridonin on atherosclerotic progression.


Ahmed Sultan
Bassim Mohammad
Najah Hadi
Azhar Al-Shaibany
Anil Philip
Dina Jamil
Hayder Al-Aubaidy https://orcid.org/0000-0001-9564-0120


Oridonin, Atherosclerosis, LC3B, Autophagy induction, Rabbits, Anti-inflammation


Background and aim: Inflammation plays a crucial role in the development of atherosclerotic plague. Oridonin is the major active ingredient of the traditional Chinese medicinal herb Rabdosia rubescens. It is a natural terpenoids that is known as a strong anti-inflammatory supplement by acting as a potent inhibitor of the TXNIP/NLRP3 pathway. Hence, it can reduce the severity of inflammation and improve the outcome of atherosclerotic changes. This study aims to evaluate the anti-inflammatory effects of oridonin in the progression of atherosclerotic plague in rabbits. Methods: Sixty-three male rabbits were included. The rabbits were randomly assigned to one of the three study groups (21 rabbits in each group), normal control diet (NC) fed normal diet for 8 weeks, atherogenic control (AC) fed atherogenic diet (2% cholesterol-enriched diet) for 8 weeks, and oridonin treated group (OT) fed atherogenic diet (2% cholesterol-enriched diet) with oridonin (purity 94%, Sigma-Aldrich, USA) at 20 mg/kg orally daily for 8 weeks. After the end of the study, blood and tissue samples were collected for analysis of various markers of inflammation and atherosclerotic plaque progression. Results: Serum lipids showed a statistically significant improvement in terms of reduction in total cholesterol and low-density lipoprotein (LDL) in the OT group compared to the AC group. This was associated with a significant reduction in serum F2-isoprostane (marker of inflammation) and LC3B (marker of tissue autophagy) between the OT group compared to the AC group. There was also a significant reduction in NLRP3 inflammasome RNA expression in OT group, P<0.001. Conclusions: In animal model, with atherogenic diet, oridonin supplementation can significantly improve the outcome of atherosclerosis by its strong anti-inflammatory action.


Download data is not yet available.
Abstract 0 |


1. Xu J, Wold EA, Ding Y, Shen Q, Zhou J. Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection. Molecules. 2018;23(2):474. doi: 10.3390/molecules23020474.
2. Liu X, Xu J, Zhou J, Shen Q. Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance. Genes Dis. 2021;8(4):448-62. doi: 10.1016/j.gendis.2020.06.010.
3. Li X, Zhang CT, Ma W, Xie X, Huang Q. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity. Front Pharmacol. 2021;12:645824. doi: 10.3389/fphar.2021.645824.
4. Gao J, Li C, Wang X, et al. Oridonin attenuates lung inflammation and fibrosis in silicosis via covalent targeting iNOS. Biomed Pharmacother. 2022;153:113532. doi.org/10.1016/j.biopha.2022.113532.
5. Li J, Bao L, Zha D, et al. Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways. Int Immunopharmacol. 2018;55:9-19. doi: 10.1016/j.intimp.2017.11.040.
6. Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117. doi: 10.1186/1741-7015-11-117.
7. Yanni AE. The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim. 2004;38(3):246-56. doi: 10.1258/002367704323133628.
8. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A. 1992;89(23):11259-63. doi: 10.1073/pnas.89.23.11259.
9. Chen Z, Liu H, Zhao X, et al. Oridonin attenuates low shear stress-induced endothelial cell dysfunction and oxidative stress by activating the nuclear factor erythroid 2-related factor 2 pathway. BMC Complement Med Ther. 2022;22(1):180. doi: 10.1186/s12906-022-03658-2.
10. Popiolek-Barczyk K, Kolosowska N, Piotrowska A, et al. Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy. Neural Plast. 2015;2015:676473. doi: 10.1155/2015/676473.
11. He H, Jiang H, Chen Y, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018;9(1):2550. doi: 10.1016/j.intimp.2017.11.040.
12. Zhao X, Zhang Q, Wang Y, et al. Oridonin induces autophagy-mediated cell death in pancreatic cancer by activating the c-Jun N-terminal kinase pathway and inhibiting phosphoinositide 3-kinase signaling. Ann Transl Med. 2021;9(13):1084. doi: 10.1038/s41467-018-04947-6.
13. Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019;20(13). doi: 10.3390/ijms20133328.
14. Lin KH, Li CY, Hsu YM, et al. Oridonin, A natural diterpenoid, protected NGF-differentiated PC12 cells against MPP(+)- and kainic acid-induced injury. Food Chem Toxicol. 2019;133:110765. doi: 10.1016/j.fct.2019.110765.